Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oral Arsenic Trioxide Formulation
DRUG
2 trials
Sponsors
The University of Hong Kong
Conditions
Acute Promyelocytic Leukemia
NPMc+ AML
Phase 2
Frontline Oral Arsenic Trioxide for APL
Recruiting
NCT04687176
The University of Hong Kong
Acute Promyelocytic Leukemia
Start: 2021-01-01
End: 2026-06-30
Target: 100
Updated: 2025-06-12
Oral Arsenic Trioxide for NPM1-mutated AML
NCT04689815
The University of Hong Kong
NPMc+ AML
Start: 2021-01-01
End: 2024-12-31
Target: 50
Updated: 2022-10-04
Related Papers
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome
Blood Advances
2024-12-18
2 citations